With my previous posts suggesting why I think there is a 90% chance that acne treatment will progress to phase 3, I find it very interesting that in past interviews with management, they do not even consider the possibility that ‘we will negotiate with the FDA if we can progress our acne treatment to phase 3’ but rather display that ‘FDA will assist us in the design of the study.” This implies that it’s already a given that they’ll progress to phase 3.
Looking Forward to a GREAT 2020, page-734
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.020(4.82%) |
Mkt cap ! $789.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 41.5¢ | $3.690M | 8.569M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66897 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 414256 | 15 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |